Showing results (271-280 of 346) with videos related to
Sort By:
Pageof 35
Biochemical Pharmacology|March 2, 1994
Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cellsS S Wong, R A Sturm, J Michel, et al.Annals of the New York Academy of Sciences|July 10, 2003
Genetic association and cellular function of MC1R variant alleles in human pigmentationR A Sturm, D L Duffy, N F Box, et al.Clinical and Experimental Immunology|August 12, 2009
Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel diseaseD C Baumgart, S Thomas, I Przesdzing, et al.Applied and Environmental Microbiology|January 7, 2009
Simultaneous interferometric measurement of corrosive or demineralizing bacteria and their mineral interfacesM S Waters, M Y El-Naggar, L Hsu, et al.Pigment Cell Research|May 20, 2003
The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypesRichard A Sturm, David L Duffy, Neil F Box, et al.Human Molecular Genetics|January 8, 2004
Interactive effects of MC1R and OCA2 on melanoma risk phenotypesDavid L Duffy, Neil F Box, Wei Chen, et al.Pigment Cell & Melanoma Research|February 28, 2012
Melanocortin-1 receptor-mediated signalling pathways activated by NDP-MSH and HBD3 ligandsKimberley A Beaumont, Darren J Smit, Yan Yan Liu, et al.Human Mutation|June 29, 2004
Novel MC1R variants in Ligurian melanoma patients and controlsLorenza Pastorino, Roberto Cusano, William Bruno, et al.American Journal of Human Genetics|January 13, 2000
Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?J S Palmer, D L Duffy, N F Box, et al.The Journal of Dermatology|July 27, 2022
Amelanotic/hypopigmented melanoma in a sibship with oculocutaneous albinismEllie J Maas, Courtney K Wallingford, Jessica J McGuire, et al.Pageof 35